Remove Development Remove DNA Remove Genotype Remove Life Science
article thumbnail

Why Proviral DNA Drug Resistance Testing is Useful in Guiding Treatment Decisions for HIV-1 Patients

XTalks

While ARV-based treatments work well to keep the virus suppressed and patients healthy — some for many years — resistance to one or more drugs in a treatment regimen can develop in some patients. HIV drug resistance occurs when virions develop mutations that make them less susceptible to given drugs. HIV Drug Resistance Testing.

DNA 98
article thumbnail

LabCorp Backs Resolution Bioscience’s Liquid Biopsy Test for NSCLC

XTalks

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The test was developed by Resolution Bioscience and the company will run test analyses in its labs. In the US, Medicare covers the test.

Gene 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Data generated through high-throughput omics approaches paired with clinical patient records can give rise to remarkably robust datasets to inform and guide disease insights and development of targeted therapeutics. Genomic biomarker discovery helps drive the development of innovative new personalized therapies. Biobanking Models.

article thumbnail

International HPV Awareness Day 2024: Spotlight on Vaccination and Early Detection

XTalks

This day acts as an opportune moment for professionals in healthcare, life sciences and related fields to highlight the importance of HPV prevention and vaccination as well as the recent advancements in screening and treatment.

article thumbnail

Why a recent advancement is a giant leap for human genomics

Drug Discovery World

The remaining 8% of the genome was often referred to as the dark matter of the genome or sometimes even ‘Junk DNA’ 2. The Telomere-to-Telomere (T2T) Consortium successfully sequenced about 200 million remaining base pairs to approach 100% of the human genome by using the newly developed long read sequencing (LRS) technology 3,4,5.

Genome 52
article thumbnail

New HIV variant highlights the importance of monitoring virus mutations

pharmaphorum

Identified as the “VB variant,” the virus has proved to be highly virulent and to speed up the progression of a patient developing AIDS faster. Therefore, the risk of developing AIDS more rapidly was higher. Unfortunately, individuals with the VB variant had viral loads between 3.5 Effects of the variant. About the author.

Genome 98